Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CAS MEDICAL SYSTEMS INC (CASM)
|
Add to portfolio |
|
|
|
| Price: |
$2.44
| | Metrics |
| OS: |
29.3
|
M
| |
|
|
| Market cap: |
$71.6
|
M
| |
-102
|
% ROIC
|
|
Net debt:
|
$6.11
|
M
| |
|
|
|
EV:
|
$77.7
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($3.4)
|
M
| |
|
|
|
EBIT
|
($4.5)
|
M
| |
|
|
| EPS |
($0.28)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 21.9 | 18.8 | 18.7 | 19.5 | 19.2 | 21.9 | 22.7 | 22.5 |
| Revenue growth | 16.8% | 0.5% | -4.2% | 1.4% | -12.3% | -3.3% | 1.0% | -6.8% |
| Cost of goods sold | 9.2 | 8.5 | 8.2 | 9.5 | 10.7 | 14.4 | 13.6 | 13.9 |
| Gross profit | 12.7 | 10.3 | 10.5 | 10.0 | 8.6 | 7.6 | 9.1 | 8.6 |
| Gross margin | 58.0% | 54.7% | 56.2% | 51.2% | 44.5% | 34.5% | 40.2% | 38.1% |
| Selling, general and administrative | 14.0 | 13.4 | 13.6 | 13.1 | 12.0 | 13.8 | 12.5 | 11.5 |
| Research and development | 3.2 | 3.2 | 3.3 | 3.5 | 3.3 | 4.2 | 4.0 | 3.5 |
| EBITA | -4.5 | -2.0 | -3.4 | -6.5 | -6.5 | -9.9 | -7.4 | -6.4 |
| EBITA margin | -20.5% | -10.7% | -18.4% | -33.3% | -34.0% | -45.4% | -32.5% | -28.4% |
| Amortization of intangibles | | | | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| EBIT | -4.5 | -2.0 | -3.4 | -6.7 | -6.7 | -10.0 | -7.4 | -6.5 |
| EBIT margin | -20.5% | -10.7% | -18.4% | -34.2% | -34.9% | -45.8% | -32.8% | -28.8% |
| Pre-tax income | -6.0 | -7.5 | -7.3 | -7.5 | -7.5 | -10.4 | -7.5 | -6.5 |
| Income taxes | 0.0 | -1.7 | -1.4 | -0.2 | 0.1 | 0.0 | -0.2 | -0.1 |
| Tax rate | 0.0% | 23.4% | 19.4% | 2.8% | | 0.0% | 2.8% | 1.9% |
| Earnings from continuing ops | -7.7 | -7.3 | -7.4 | -8.7 | -8.9 | -11.6 | -8.4 | -7.0 |
| Earnings from discontinued ops | | 3.4 | 2.8 | 0.4 | | | | 0.2 |
| Net income | -7.7 | -3.9 | -4.6 | -8.3 | -8.9 | -11.6 | -8.4 | -6.7 |
| Net margin | -35.0% | -20.9% | -24.9% | -42.5% | -46.3% | -52.8% | -37.2% | -29.9% |
| |
| Diluted EPS | ($0.28) | ($0.27) | ($0.28) | ($0.34) | ($0.46) | ($0.73) | ($0.63) | ($0.53) |
| Shares outstanding (diluted) | 27.8 | 27.3 | 26.8 | 25.7 | 19.2 | 15.8 | 13.3 | 13.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|